Literature DB >> 25108442

[Amplification efficency and optimization of culture conditions of γδ T cells in peripheral blood by different phosphate compounds].

Yan Xi1, Tianyu Miao2, Like Wan1, Yuanhu Wang1, Ting Feng2, Tianxiang Gong1, Mingyuan Li3.   

Abstract

OBJECTIVE: To compare the efficiency of pamidronate (PAM) and isopentenyl pyrophosphate (IPP) to stimulate γδ T cell expansion from human peripheral blood and explore the optimized expansion conditions.
METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Paque gradient centrifugation, and then cultured in RPMI1640 medium supplemented with 10% fetal bovine serum, IPP (1.0, 5.0, 10.0, 15.0 μg/mL) or PAM (2.0, 5.0, 8.0, 12.0 μg/mL), and IL-2 (100.0, 200.0, 500.0 IU/mL). The cells were observed and collected. The number and proportion of CD3⁺TCRδ2⁺ γδ T cells stimulated by PAM or IPP in total lymphocytes were evaluated by flow cytometry and the expansion efficiency was calculated.
RESULTS: After 14 days, the ratios of γδ T cells in total lymphocytes in IPP group and PAM group increased to 81.3% and 78.5%, respectively. This indicated that both IPP and PAM could effectively stimulate γδ T cell expansion and there was no significant difference in the efficiency of expansion between the two groups (P>0.05).
CONCLUSION: PAM has the similar ability with IPP to stimulate γδ T cell expansion in vitro. PAM could become more economical and practical choice for stimulating γδ T cell expansion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25108442

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  1 in total

Review 1.  Protective Role of γδ T Cells in Different Pathogen Infections and Its Potential Clinical Application.

Authors:  Yueshui Zhao; Ling Lin; Zhangang Xiao; Mingxing Li; Xu Wu; Wanping Li; Xiaobing Li; Qijie Zhao; Yuanlin Wu; Hanyu Zhang; Jianhua Yin; Lingling Zhang; Chi Hin Cho; Jing Shen
Journal:  J Immunol Res       Date:  2018-07-10       Impact factor: 4.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.